Effects of prenatal opioid exposure on functional networks in infancy

Effects of prenatal opioid exposure on functional networks in infancy

Prenatal opioid exposure has been linked to altered neurodevelopment and visual problems such as strabismus and nystagmus. The neural substrate underlying these alterations is unclear. Resting-state functional connectivity MRI (rsfMRI) is an advanced and well-established technique to evaluate brain...

Full description

Bibliographic Details
Main Authors:	Stephanie L. Merhar, Weixiong Jiang, Nehal A. Parikh, Weiyan Yin, Zhen Zhou, Jean A. Tkach, Li Wang, Beth M. Kline-Fath, Lili He, Adebayo Braimah, Jennifer Vannest, Weili Lin
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Series:	Developmental Cognitive Neuroscience
Subjects:	Neonatal Opioid Neonatal opioid withdrawal syndrome Functional MRI Functional connectivity Magnetic resonance imaging
Online Access:	http://www.sciencedirect.com/science/article/pii/S1878929321000864

Similar Items

Prenatal Exposures Are Associated With Worse Neurodevelopmental Outcomes in Infants With Neonatal Opioid Withdrawal Syndrome
by: Kristen L. Benninger, et al.
Published: (2020-08-01)

Effect of Prenatal Opioid Exposure on the Human Placental Methylome
by: Kristyn N. Borrelli, et al.
Published: (2022-05-01)

Prenatal Opioid Exposure and ADHD Childhood Symptoms: A Meta-Analysis
by: Ashlyn N. Schwartz, et al.
Published: (2021-02-01)

A state-level study of opioid use disorder treatment access and neonatal abstinence syndrome
by: Elizabeth R. Wolf, et al.
Published: (2019-10-01)

Sex differences in neonatal outcomes following prenatal opioid exposure
by: Nethra K. Madurai, et al.
Published: (2024-03-01)

Economic Evaluation of Interventions for Treatment of Neonatal Opioid Withdrawal Syndrome: A Review
by: Evelyn Lee, et al.
Published: (2021-06-01)

Opioid withdrawal behavior in spiny mice: A novel preclinical model of neonatal opioid withdrawal syndrome (NOWS)
by: Sarah Stevens, et al.
Published: (2021-04-01)

Outcome reporting in neonates experiencing withdrawal following opioid exposure in pregnancy: a systematic review
by: Flora Shan, et al.
Published: (2020-03-01)

Pregnant women misusing opioids: Depression, anxiety, stress, and neonatal opioid withdrawal syndrome
by: Samantha Noose Glovak, MA, et al.
Published: (2020-12-01)

Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)
by: Adam Czynski, et al.
Published: (2023-07-01)

Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome
by: Uppala Radhakrishna, et al.
Published: (2023-06-01)

Molecular and long-term behavioral consequences of neonatal opioid exposure and withdrawal in mice
by: Amelia D. Dunn, et al.
Published: (2023-06-01)

Pharmacological Prevention of Neonatal Opioid Withdrawal in a Pregnant Guinea Pig Model
by: Alireza Safa, et al.
Published: (2021-02-01)

Stopping or Decreasing Opioid Therapy in Patients on Chronic Opioid Therapy
by: Joseph V. Pergolizzi, et al.
Published: (2019-08-01)

Developmental implications of prenatal opioid exposure among school-aged children: a mixed methods and community-initiated analysis
by: Andra Wilkinson, et al.
Published: (2023-09-01)

Placental OPRM1 DNA methylation and associations with neonatal opioid withdrawal syndrome, a pilot study
by: Elisha M. Wachman, et al.
Published: (2020-06-01)

County-level neonatal opioid withdrawal syndrome rates and real-world access to buprenorphine during pregnancy: An audit (“secret shopper”) study in Missouri
by: Bronwyn S. Bedrick, et al.
Published: (2024-03-01)

A mini review of what matters in the management of NAS, is ESC the best care?
by: Enrique Gomez Pomar, et al.
Published: (2023-07-01)

Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study
by: Mary Beth Sutter, et al.
Published: (2022-06-01)

Biased Opioid Antagonists as Modulators of Opioid Dependence: Opportunities to Improve Pain Therapy and Opioid Use Management
by: Wolfgang Sadee, et al.
Published: (2020-09-01)

Research and policy priorities for addressing prenatal exposure to opioids in Alaska
by: Rosalyn Singleton, et al.
Published: (2019-01-01)

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
by: Niraj R. Chavan, et al.
Published: (2017-10-01)

In utero and post-natal opioid exposure followed by mild traumatic brain injury contributes to cortical neuroinflammation, mitochondrial dysfunction, and behavioral deficits in juvenile rats
by: Austin M. Gowen, et al.
Published: (2023-10-01)

“It’s a proactive intervention instead of a reactive one”: measuring facilitators and barriers regarding readiness to implement a treatment program for infants with neonatal opioid withdrawal syndrome
by: Leah Holcomb, et al.
Published: (2023-07-01)

Opioid withdrawal presenting as delirium and role of buprenorphine: A case series
by: Sourav Das, et al.
Published: (2017-01-01)

Pharmacological Strategies for Decreasing Opioid Therapy and Management of Side Effects from Chronic Use
by: Genevieve D’Souza, et al.
Published: (2018-12-01)

The Epidemic of Neonatal Abstinence Syndrome, Historical References of Its’ Origins, Assessment, and Management
by: Enrique Gomez-Pomar, et al.
Published: (2018-02-01)

Pilot Study Comparing Adverse Cardiorespiratory Events among Pharmacologically and Nonpharmacologically Treated Infants Undergoing Monitoring for Neonatal Abstinence Syndrome
by: Spoorthi Davala, BA, et al.
Published: (2020-01-01)

Fetal and Infant Effects of Maternal Opioid Use during Pregnancy: A Literature Review including Clinical, Toxicological, Pharmacogenomic, and Epigenetic Aspects for Forensic Evaluation
by: Elena Giovannini, et al.
Published: (2024-02-01)

Transcutaneous Auricular Neurostimulation (tAN): A Novel Adjuvant Treatment in Neonatal Opioid Withdrawal Syndrome
by: Dorothea D. Jenkins, et al.
Published: (2021-03-01)

A Systematic Review of Clinical Practice Guidelines for Neonatal Abstinence Syndrome
by: Zoe Wei, et al.
Published: (2023-10-01)

The Role of Lofexidine in Management of Opioid Withdrawal
by: Joseph V. Pergolizzi, et al.
Published: (2018-12-01)

Project BETTER: A Family-Centered, Technology-Delivered Intervention for Pregnant People with Opioid Use Disorder
by: Anna Beth Parlier-Ahmad, et al.
Published: (2023-02-01)

Single high-dose buprenorphine for opioid craving during withdrawal
by: Jamshid Ahmadi, et al.
Published: (2018-12-01)

Case report: The lesson from opioid withdrawal symptoms mimicking paraganglioma recurrence during opioid deprescribing in cancer pain
by: Elena Ruggiero, et al.
Published: (2023-09-01)

A Retrospective Review Following the Addition of Clonidine to a Neonatal Abstinence Syndrome Treatment Algorithm
by: Mohammad Y. Bader, et al.
Published: (2021-06-01)

Placental cytochrome P450 methylomes in infants exposed to prenatal opioids: exploring the effects of neonatal opioid withdrawal syndrome on health horizons
by: Uppala Radhakrishna, et al.
Published: (2024-01-01)

Understanding the effects of opioids vs non-opioids in the treatment of neonatal abstinence syndrome, an in vitro model
by: Thitinart Sithisarn, et al.
Published: (2022-11-01)

Evaluating a web-based training curriculum for disseminating best practices for the care of newborns with neonatal opioid withdrawal syndrome in a rural hospital, the NOWS-NM Program
by: Heather Pratt-Chavez, et al.
Published: (2024-04-01)

Postnatal oxytocin treatment improves survival and neurodevelopmental outcomes in an animal model of neonatal abstinence syndrome
by: Dean S. Carson, et al.
Published: (2022-08-01)